A venture-focused newsletter cites a survey of 500 US consumers to declare a healthmaxxing economy built on biomarker tracking and personalized supplementation, even as a separate wellness-industry forecast argues for the opposite: a backlash against over-optimization and a turn toward presence over measurement.